Ulla Johansson

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

Linda S. Lindström, Eva Karlsson, Ulla Wilking et al. · Journal of Clinical Oncology · 2012 · 535 citations

Medicine, Oncology, Pathology +13

<i>TP53</i> mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains

Anne‐Lise Børresen, Tone Ikdahl Andersen, Jórunn E. Eyfjörd et al. · Genes Chromosomes and Cancer · 1995 · 181 citations

Medicine, Molecular Biology, Oncology +15

Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial

Mia Fahlén, Tommy� Fornander, Hemming Johansson et al. · European Journal of Cancer · 2012 · 154 citations

Medicine, Endocrinology, Oncology +11

Postmenopausal breast cancer is associated with high intakes of ω6 fatty acids (Sweden)

Elisabet Wirfält, Iréne Mattisson, Bo Gullberg et al. · Cancer Causes & Control · 2002 · 91 citations

Agriculture, Nutrition, Nutritional Sciences +13

Rapid purification of monoclonal antibodies by high-performance liquid chromatography

Bohdan Pavlu, Ulla Johansson, Christina Nyhlén et al. · Journal of Chromatography A · 1986 · 61 citations

Pharmacy, Biochemistry, Molecular Biology +16